Universidad: Salamanca

Forschungsgruppe: NEUROBIOQUÍMICA

Email: andrea.av@usal.es

Doktorin von der Universidad de Salamanca mit der Dissertation Translational steps towards the clinical application of tat-cx43266-283 for the treatment of glioblastoma egfr as a predictor and mediator of treatment response, and positive results in combination with tumor resection in a preclinical model 2024. unter der Leitung von Dr. María Aránzazu Tabernero Urbieta.